Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,503,854
  • Shares Outstanding, K 34,371
  • Annual Sales, $ 0 K
  • Annual Income, $ -70,430 K
  • 36-Month Beta 2.14
  • Price/Sales 263.56
  • Price/Cash Flow N/A
  • Price/Book 10.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.80
  • Number of Estimates 6
  • High Estimate -0.62
  • Low Estimate -0.90
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -19.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.13 +20.77%
on 01/29/19
76.00 -4.45%
on 02/15/19
+7.82 (+12.07%)
since 01/15/19
3-Month
34.39 +111.17%
on 12/24/18
76.00 -4.45%
on 02/15/19
+33.82 (+87.16%)
since 11/15/18
52-Week
24.65 +194.60%
on 04/06/18
76.00 -4.45%
on 02/15/19
+43.62 (+150.41%)
since 02/15/18

Most Recent Stories

More News
Mirati Therapeut Up 73.3% Since SmarTrend Uptrend Call (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on December 28th, 2018 at $41.55. In approximately 2 months, Mirati Therapeut has returned 73.29% as of today's recent price of $72.00....

MRTX : 72.62 (-0.32%)
Mirati Therapeutics To Present At The Guggenheim Healthcare Talks Idea Forum & Oncology Day

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will participate in the Guggenheim Healthcare Talks Idea Forum & Oncology Day in New York on Thursday, February 14th...

MRTX : 72.62 (-0.32%)
Uptrend Call Working As Mirati Therapeut Stock Rises 62.9% (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on December 28th, 2018 at $41.55. In approximately 1 month, Mirati Therapeut has returned 62.86% as of today's recent price of $67.67....

MRTX : 72.62 (-0.32%)
Look for Shares of Mirati Therapeut to Potentially Pullback after Yesterday's 1.11% Rise

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $68.41 to a high of $68.73. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high...

MRTX : 72.62 (-0.32%)
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the closing of its previously announced underwritten public offering of 1,854,838 shares of its common stock at a public offering price of $62.00...

JPM : 105.55 (+3.06%)
MRTX : 72.62 (-0.32%)
Mirati Therapeut Up 56.2% Since SmarTrend Uptrend Call (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on December 28th, 2018 at $41.55. In approximately 3 weeks, Mirati Therapeut has returned 56.25% as of today's recent price of $64.92....

MRTX : 72.62 (-0.32%)
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 1,612,903 shares of its common stock at a price to the public of $62.00 per share. The aggregate...

MRTX : 72.62 (-0.32%)
Mirati Therapeutics Announces Dosing Of First Patient In Phase 1/2 Clinical Trial Of MRTX849, A Novel KRAS G12C Inhibitor

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, announced today that it has dosed the first patient in a Phase 1/2 clinical trial of MRTX849, an investigational KRAS...

MRTX : 72.62 (-0.32%)
Uptrend Call Working As Mirati Therapeut Stock Rises 46.3% (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on December 28th, 2018 at $41.55. In approximately 2 weeks, Mirati Therapeut has returned 46.31% as of today's recent price of $60.79....

MRTX : 72.62 (-0.32%)
Mirati Therapeutics (MRTX) Catches Eye: Stock Jumps 5.4%

Mirati Therapeutics (MRTX) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

ACOR : 14.30 (-8.10%)
MRTX : 72.62 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MRTX with:

Business Summary

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

See More

Key Turning Points

2nd Resistance Point 78.37
1st Resistance Point 75.50
Last Price 72.62
1st Support Level 70.25
2nd Support Level 67.87

See More

52-Week High 76.00
Last Price 72.62
Fibonacci 61.8% 56.38
Fibonacci 50% 50.33
Fibonacci 38.2% 44.27
52-Week Low 24.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar